Gabapentin
Product Images NDC 17856-1311

5 FDA label images from Atlantic Biologicals Corps · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 17856-1311). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Atlantic Biologicals Corps, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 01)

Chemical Structure (Image 01)
Chemical structure of Gabapentin showing a cyclohexane ring with an aminomethyl and an acetic acid side group attached.*
FDA Label Image

Figures 1 & 2 (Image 02)

Figures 1 & 2 (Image 02)
Two line graphs showing weekly mean pain scores over multiple weeks. The first graph compares placebo and Gabapentin 300 mg/day with a stable trend. The second graph compares placebo and Gabapentin at 1800 mg/day and 2400 mg/day with decreasing pain scores over 7 weeks. The study is identified as ITT Population: Study 1.*
FDA Label Image

Figure 3 (Image 03)

Figure 3 (Image 03)
A bar chart titled 'Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' comparing response rates between placebo (PBO) and gabapentin (GBP) at different dosages across two studies. The vertical axis shows percent responders from 0% to 100%. Study 1 compares PBO and GBP 3600, with respective response rates of 12% and 29%. Study 2 compares PBO, GBP 1800, and GBP 2400, with response rates of 14%, 32%, and 34% respectively.*
FDA Label Image

Figure 4 (Image 04)

Figure 4 (Image 04)
A chart showing difference (%) on the y-axis plotted against daily dose (mg) on the x-axis for Gabapentin at doses 600, 900, 1200, and 1800 mg. The data points are presented for three separate studies labeled as Study a, Study b, and Study c, each represented by different symbol shapes and shades.*
FDA Label Image

Label Image (Lbl178561311)

Label Image (Lbl178561311)
Gabapentin 250 mg per 5 mL oral solution label from Atlantic Biologicals Corps. The label specifies the concentration as 250 mg per 5 mL (50 mg/mL), with a dosing cup of 5 mL provided. Storage instructions indicate refrigeration at 2-8°C. The product is for prescription use only and includes manufacturer and distributor details, lot numbers, expiration date, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.